The results obtained show that CENPO was up-regulated in most cancers (Fig. 2C), including BLCA, BRCA, CESC, CHOL, COAD, ESCA, GBM, HNSC, LIHC, LUAD, LUSC, prostate adenocarcinoma (PRAD), READ, STAD, and UCEC. Here, CENPO is linked to cancer.